Dubielecka-Szczerba, Patrycja Marta
- Rhode Island Hospital · Internal Medicine (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #32,236
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$360.9K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#32,236
By linked amount among FY2023 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Dubielecka-Szczerba, Patrycja Marta as a PI. Multi-PI records show the full award amount for context.
- 5R01CA218079-05R01Contact PIThe role of Abelson interactor 1 (Abi-1) in hematopoietic stem cell self-renewal and malignant transformationRhode Island Hospital · Internal Medicine (investigator's affiliation)$360.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Dubielecka-Szczerba, Patrycja Marta as a PI.
FY2023 award administered by Rhode Island Hospital (RI).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardRhode Island Hospital
- 2021$500K Cumulative Funding
- 2021R01 Grant Holder
- 2022$1M Cumulative Funding